Justin Crowther

Justin Crowther
T: +44 (0) 115 957 8236
T: +44 (0) 20 7246 0500
E: justincrowther@catalystcf.co.uk

Justin is a Partner and has over 15 years of successful transaction advisory experience at Catalyst.

Justin leads Catalyst's Healthcare sector team. Recent transactions include advising Spectris plc on its £163m acquisition of Concept Life Sciences; the merger of Options Group with Outcomes First Group, the sales of Raphael HealthcareFocus Pharmaceuticals, the ARX Group, Williams Medical Supplies and Solor Care, and the management buy-outs of Addo Food Group, 4Ways Healthcare and NRS.

He regularly writes for the sector's leading publications including HealthInvestor and Caring Times, and is often sought out by the national press, including the Financial Times, for his opinions. Justin is also one of the authors of the Catalyst Pharma Fast 50.

Born and bred in Nottingham, Justin leads our presence with Simon Peacock in the East Midlands market, using his extensive connections with the region's corporate mid-market and intermediary professionals.

A graduate of Newcastle University, Justin trained as a chartered accountant with KPMG before moving onto the corporate development team of the then FTSE 100 company, Boots plc. Justin joined Catalyst in 2000.

A member of the Catalyst 'two daughters' club, Justin combines his family duties with honing his tennis skills and taking as many opportunities as possible to play golf.


Catalyst advises Spectris plc on its acquisition of Concept Life Sciences

Catalyst Corporate Finance has advised Spectris plc, the productivity-enhancing instrumentation and controls company, on its acquisition of Concept Life Sciences.  

Advisor to WernerCo and Triton Partners on the acquisition of Zarges Group

We advised WernerCo and Triton Partners on the acquisition of Zarges Group, a leading provider of professional access, storage and special construction solutions. 

Catalyst advises Piper on investment in Neom Organics

Catalyst has advised Piper on its investment in beauty and wellbeing brand Neom Organics (“Neom”). 

Catalyst advises Synova on 4Ways Healthcare refinancing

We advised Synova Capital on its refinancing of portfolio company 4Ways Healthcare, a leading provider of tele-diagnostic services to the healthcare sector.  

Catalyst advises PCMS Group on its sale to a management buy-out team backed by Inflexion Private Equity

Catalyst has advised PCMS Group, a leading provider of point-of-sale software and services for major retailers, on its sale to a management buy-out team, backed by Inflexion.